
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 26, 2024, titled "Zydus receives final approval from USFDA for Tretinoin Cream USP, 0.1%".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 26, 2024, titled "Zydus receives final approval from USFDA for Tretinoin Cream USP, 0.1%".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences